Novelab
Novelab is a French multi-site medical biology laboratory group operating 24 walk-in laboratory sites across the Lyon periphery, Ain, and Mâconnais regions, serving individual patients, referring physicians, clinics, and nursing homes with NABM-reimbursed analyses, specialized reproductive biology, and out-of-pocket screening panels under ISO 15189 V2022 quality standards.
- Company typePrivate
- Founded2011
- HeadquartersCorcelles-en-beaujolais, France
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Novelab does
Novelab is a France-based multi-site medical biology laboratory group operating 24 physical laboratory sites across the Lyon periphery, the Ain department, and the Mâconnais region in southeast France. Founded in its current form in 2011 through the fusion of several legacy entities (dating back to 2005), the group is structured as a SELAS (Société d'Exercice Libéral par Actions Simplifiée) and is collectively owned by independent liberal biologists — both physicians and pharmacists — affiliated with the Groupement des Laboratoires de Biologie Indépendante (LBI). Novelab employs 150+ staff including biologists, qualified technicians, nurses, couriers, and support personnel, and conducts the vast majority of routine medical biology analyses in-house, outsourcing approximately 2% of specialized volume to Eurofins-Biomnis and the Établissement Français du Sang (EFS).
The group's service portfolio is anchored by routine NABM-reimbursed analyses (blood draws, urine tests, screenings) under the French Sécurité Sociale framework, complemented by specialized reproductive biology services (spermogram, TMS, spermoculture, MAR test, IAC/IUU intrauterine insemination) at three PMA-approved sites, as well as PCR COVID testing and a growing catalog of out-of-pocket sans-ordonnance panels (check-up €50, metabolic €45, fatigue €60, hormonal €42, STI panel). Technology infrastructure centers on ISO 15189 V2022 quality management, the MyKali secure online results portal, Doctolib appointment booking for specialized tests, and Identité Nationale de Santé (INS) identity verification, with ongoing lab-process automation investments such as the Beckman DxA chain at the Grand Laboratoire d'Ambérieu.
Commercially, Novelab pursues a hybrid direct-to-consumer and sales-led GTM: patients walk in without appointment at most sites Monday through Saturday, while a parallel referral-driven channel pulls volume from prescribing physicians, gynecologists, polyclinics, nursing homes, and liberal nurses operating in the territory. Recent geographic expansion (Charvieu-Chavagneux September 2025, Saint-Maurice-de-Beynost February 2026) and a sustained M&A track record (eight acquisitions or fusions since 2012) demonstrate a controlled roll-up strategy, while growing participation in CPTS (Communautés Professionnelles Territoriales de Santé) and urgent-care health centers signals increasing integration into the regional primary-care ecosystem.
Novelab firmographics
Firmographics- Name
- Novelab
- Legal name
- NOVELAB S.E.L.A.S.
- Website
- https://novelab.fr
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Novelab is a French multi-site medical biology laboratory group operating 24 walk-in laboratory sites across the Lyon periphery, Ain, and Mâconnais regions, serving individual patients, referring physicians, clinics, and nursing homes with NABM-reimbursed analyses, specialized reproductive biology, and out-of-pocket screening panels under ISO 15189 V2022 quality standards.
- Ownership category
- akta.pro rank
Novelab industry classification
Industry- Product category
- Medical Laboratory Services
- NAICS
- Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)
Keywords
Where Novelab is headquartered
LocationHeadquarters
- HQ city
- Corcelles-en-beaujolais
- HQ country
- France
- HQ region
- Europe
Offices24 records
Markets served
Novelab business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Medical Biology Analyses (NABM Reimbursement): The majority of revenue is generated through reimbursable medical biology analyses billed under the Nomenclature des Actes de Biologie Médicale (NABM) to the French national health insurance (Sécurité Sociale). Prices are regulated and periodically reduced by the Assurance Maladie. Some analyses are classified hors nomenclature (HN) and charged additionally to the patient.
- Out-of-Pocket Tests (Sans Ordonnance): Novelab offers certain tests without a prescription at fixed patient-paid prices (e.g., check-up package €50, beta-HCG pregnancy test €20, glycemia €16, ECBU €20, metabolic panel €45, fatigue panel €60, hormonal panel €42). These are paid directly by patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Check-up package (Bilan Check-up) |
| Unit Pricing | Pay-as-you-go | Beta-HCG pregnancy test (sans ordonnance) |
| Unit Pricing | Pay-as-you-go | Glycemia (diabetes screening, sans ordonnance) |
| Unit Pricing | Pay-as-you-go | ECBU - urinary infection screening (sans ordonnance) |
| Unit Pricing | Pay-as-you-go | Metabolic panel - diabetes and cardiovascular risk (sans ordonnance) |
| Unit Pricing | Pay-as-you-go | Fatigue panel (sans ordonnance) |
| Unit Pricing | Pay-as-you-go | Hormonal panel - menopause assessment (sans ordonnance) |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Novelab product offering
Product offeringCore offering
Novelab operates 24 medical biology laboratories across the Lyon periphery, Ain, and M\u00e2connais regions of France, performing routine medical biology analyses (blood draws, urine tests, microbiology) primarily reimbursed through the French national health insurance under NABM. The group offers specialized reproductive biology services (spermogram, spermoculture, intrauterine insemination) at three dedicated sites, PCR COVID testing, and self-paid health check-up packages without prescription. Patients access services via walk-in (no appointment required for most blood draws), Doctolib online booking for specialized tests, and retrieve results via the MyKali online portal.
Product overview
Novelab is a multi-site medical biology laboratory group consisting of 24 laboratory sites across the Lyon periphery, Ain, and Mâcon regions. The company offers a unified platform of services anchored by routine medical biology analyses (blood tests, urine tests) performed across all sites, complemented by specialized reproductive biology services including spermogram/TMS and intrauterine insemination (IUU/IAC) at designated locations. Additional offerings include PCR COVID testing, IST screening, and various health check-up packages available without prescription. Patients access results through an online portal and can book appointments via Doctolib. Specialized analyses (2% of volume) are outsourced to partners EUROFINS-BIOMNIS and EFS.
Differentiator
Problem solved
Functional benefit
Products and services
- Routine Medical Biology Analyses Comprehensive range of routine medical biology tests including blood draws, urine tests, and other analyses performed across all 24 Novelab laboratory sites. Available to patients both with and without physician prescription, with most tests reimbursed under the French NABM nomenclature.
- Spermiology Services Specialized reproductive biology services including spermogram, test de migration-survie (TMS), spermoculture, MAR test, and sperm DNA fragmentation analysis, available by appointment at designated Novelab sites.
- Intrauterine Insemination (IUI/IAC) Intrauterine insemination (IUU/IAC) with approved biologists for sperm analysis, preparation, and insemination support at dedicated Novelab sites. Up to 6 covered attempts available per French social security reimbursement rules.
- Test Post Coital (TPC/Huhner) Post-coital cervical mucus test performed during the pre-ovulatory period to evaluate cervical mucus permeability to spermatozoa, available at three designated Novelab sites.
- PCR COVID Testing COVID-19 PCR testing available with or without appointments depending on symptomatic status, with result reporting to the SIDEP national database, performed at multiple Novelab laboratory sites including Villefranche-sur-Sa\u00f4ne.
- IST Screening (Mon Test IST) Comprehensive sexually transmitted infection screening package covering HIV, Hepatitis B, Hepatitis C, Syphilis, Chlamydia, and Gonorrhea, available without prescription and fully covered for under-26 patients under French social security.
- Bilan Check-up (Complete Check-up Package) Full check-up screening panel priced at €50 covering complete blood count, ferritin, TSH, kidney function, electrolytes, liver enzymes, CRP, glycemia, full lipid profile, uric acid, calcium, and vitamin D, available without a prescription.
- Bilan Fatigue (Fatigue Panel) Fatigue assessment panel including NFS, ferritin, glycemia, transaminases, CRP, electrolytes, vitamin D, folate B9, vitamin B12, calcium, and magnesium, priced at €60 without prescription.
- Bilan M\u00e9tabolique (Metabolic/Diabetes-Cardiovascular Panel) Metabolic and cardiovascular risk screening covering glycemia, insulin/HOMA/QUICKI, lipid profile, uric acid, kidney function, and electrolytes, priced at €45 without prescription.
- Bilan Hormonal (Menopause Hormonal Panel) Hormonal panel measuring FSH and estradiol for menopause assessment, priced at €42 without prescription.
- ECBU (Cytobacteriological Urine Examination) Cytobacteriological examination of urine for diagnosing urinary tract infections, priced at €20 without prescription.
- Beta-hCG Pregnancy Test Blood-based pregnancy testing via beta-hCG hormone dosage, priced at €20 without prescription.
- MyKali Online Results Portal Patient-facing web portal for securely accessing test results online via email notification, providing permanent password access for 180 days for result retrieval.
Companies that use Novelab
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles2 records
Novelab technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
Feature3 records
Novelab partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- Colloquium en Calade - Reproductive Biology PartnersminorAnnual scientific colloquium on infertility held in the Beaujolais region. Partners include: Theradiag, IBSA France, Organon France, Eugin, Ferring Pharmaceuticals France, Merck, Theramex, Gedeon Richter France, Institut Marquès, Barcelona IVF, EFFIK. Novelab is a sponsoring partner.
- Eurofins-BiomniscoreEurofins-Biomnis is a specialized medical biology laboratory providing reference analyses not performed in-house. Novelab refers approximately 2% of its analysis volume to Eurofins-Biomnis for specialized testing.
- EFS (Établissement Français du Sang)coreThe French Blood Establishment provides specialized blood banking and transfusion-related analyses. Novelab partners with EFS for the 2% of specialized volume that requires external laboratory services.
Scale indicators5 records
Recent moves9 records
Expansion highlights6 records
Novelab competitors and assessment
Company assessmentOthers
- Doctolib: Not a lab but a critical ecosystem partner integrated by Novelab for online appointment booking. Listed as OTHERS because it is an enabling technology platform that channels patient demand to Novelab's specialized services rather than a direct lab competitor.
Broad incumbents
- Unilabs: European diagnostics provider with French operations covering routine and specialty medical biology. Comparable as a multi-site medical laboratory serving physicians, clinics, and patients across regions of France.
- Synlab: Major pan-European medical diagnostics provider with a significant French laboratory footprint. Comparable as a multi-site routine and specialized medical biology operator serving physicians, clinics, and patients across regional France.
- Inovie: French medical biology network consolidating independent labs nationally. Closely comparable in business model (multi-site routine biology + specialty) and explicitly competes for the same independent-lab consolidation pipeline as Novelab.
- Eurofins-Biomnis: Specialized reference laboratory partner to which Novelab outsources 2% of its volume. Directly comparable as a French medical biology testing provider, with a much broader specialty test menu and national footprint.
- Cerba HealthCare: One of the largest French/European medical biology networks, offering routine and specialized lab services. Comparable as a multi-site laboratory group serving French clinicians, though at significantly larger scale and broader geographic reach than Novelab.
- Laboratoire Pasteur-Cerba: Specialized French medical biology lab offering routine and reference testing. Comparable in test menu and physician-referral channels, though primarily positioned as a specialty/reference lab rather than a multi-site walk-in network.
- Biogroup: Major French independent laboratory network operating regional multi-site biology platforms. Directly comparable as a regional multi-site group offering routine analyses, reproductive biology, and physician referral services.
Regional players
- Centre de Biologie Médicale (CBM): Regional French medical biology laboratory network offering routine analyses with multi-site presence. Comparable as a French regional multi-site laboratory group with similar NABM-reimbursed business model, though not necessarily overlapping Novelab's Lyon/Ain/Mâconnais territory.
Direct peers
- Laboratoire de Biologie Médicale (LBI Groupement): Umbrella organization of independent French medical biologists of which Novelab is a member. Comparable as a federation of independent regional lab groups adhering to similar operating, quality, and governance models.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Novelab social profiles
Digital presenceNovelab compliance and trust
Trust signalCompliance3 records
Novelab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Novelab leadership team
Management profileNumber of profiles
Profiles3 records
Novelab subsidiaries and ownership
Company hierarchySubsidiaries24 records
Novelab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Novelab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Novelab
What does Novelab do?
Novelab operates 24 medical biology laboratories across the Lyon periphery, Ain, and M\u00e2connais regions of France, performing routine medical biology analyses (blood draws, urine tests, microbiology) primarily reimbursed through the French national health insurance under NABM. The group offers specialized reproductive biology services (spermogram, spermoculture, intrauterine insemination) at three dedicated sites, PCR COVID testing, and self-paid health check-up packages without prescription. Patients access services via walk-in (no appointment required for most blood draws), Doctolib online booking for specialized tests, and retrieve results via the MyKali online portal.
Is Novelab a public or private company?
Novelab is a private company. It is classified as management employee owned and is currently operating.
When was Novelab founded?
Novelab was founded in 2011. It employs 101 to 250 people.
Where is Novelab based?
Novelab is headquartered in Corcelles-en-beaujolais, France, in the Europe region.
How does Novelab make money?
Two revenue lines are on record. Medical Biology Analyses (NABM Reimbursement) is the primary driver. The others are out-of-Pocket Tests (Sans Ordonnance).
Who are Novelab's main competitors?
Doctolib is listed as an others. Broad incumbents are Unilabs, Synlab, Inovie, Eurofins-Biomnis, Cerba HealthCare, Laboratoire Pasteur-Cerba and Biogroup. Centre de Biologie Médicale (CBM) is listed as a regional player. Laboratoire de Biologie Médicale (LBI Groupement) is listed as a direct peer.
Does Novelab have an API?
No public API is recorded for Novelab.
What industry is Novelab in?
Novelab's product category is Medical Laboratory Services. Its primary akta.pro industry code is HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories. Its NAICS code is 6215 and its SIC code is 8071.